Business UpdateAug 11, 2026, 08:32 AM
Conexeu Sciences CMO to Present on Tissue Regeneration
AI Summary
Conexeu Sciences announced that its Chief Medical Officer, Dr. Brian Pilcher, will present at the Controversies & Conversations in Laser & Cosmetic Surgery Symposium on August 15, 2026. Dr. Pilcher's presentation will focus on the role of the extracellular matrix (ECM) in tissue regeneration and how ECM-based approaches can advance regenerative aesthetics. This aligns with Conexeu's efforts to develop tissue-restoration technologies, including its CXU™ platform and Ten-Minute Tissue™ device, with an anticipated 510(k) submission in early 2027.
Key Highlights
- Dr. Brian Pilcher, Conexeu Sciences' Chief Medical Officer, will present at the Controversies & Conversations in Laser & Cosmetic Surgery Symposium.
- The presentation, titled "Beyond Filling: An Extracellular Matrix Blueprint for Tissue Regeneration," will occur on August 15, 2026.
- Dr. Pilcher will discuss the role of the extracellular matrix (ECM) in tissue regeneration and ECM-based approaches for regenerative aesthetics.
- Conexeu's patented CXU™ extracellular matrix platform is designed to support bioregeneration across multiple markets.
- The company's lead device candidate, Ten-Minute Tissue™, is a thermosensitive ECM designed for soft tissue regeneration.
- Conexeu anticipates a 510(k) submission in early 2027 for its initial indication.
Price Impact
More from CNXU